Improzone

Improzo
  • 0,0 (0)
  • Biowissenschaften
  • Monatlich

You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.

  1. Season 2 Episode 4.3 CRM Reimagined: The Future of CRM in Life Sciences

    24. Juni

    Season 2 Episode 4.3 CRM Reimagined: The Future of CRM in Life Sciences

    Season 2 Miniseries Episode 4.3 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore what the future of CRM in life sciences could look like and why the next evolution of CRM is less about technology and more about creating value for the people who use it every day. Key takeaways: Why CRM must evolve from a compliance tool into a system that genuinely supports field teams How poor data quality and low adoption create a cycle that limits the value of both CRM and AI Where AI is already delivering impact today, from voice-enabled call reporting to next best actions Why earning trust through small, practical AI wins matters more than ambitious "slideware" promises The three priorities leaders should focus on: strong data foundations, accurate field models, and targeted automation Why CRM decisions should be treated as a commercial strategy, not just an IT implementation A thought-provoking conversation on putting the "relationship" back into customer relationship management and building systems that work better for both people and business outcomes. #ImprozonePodcast #CRM #LifeSciences #ArtificialIntelligence #PharmaTech #DigitalTransformation #CommercialOperations #CustomerExperience #Improzo

    25 Min.
  2. Season 2 Episode 4.2 CRM Reimagined: Present Day Realities

    20. Mai

    Season 2 Episode 4.2 CRM Reimagined: Present Day Realities

    Season 2 Miniseries Episode 4.2 is officially live.New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the present-day realities of CRM transformation, where life sciences, data, and technology intersect, and where teams are now being forced to make some of their most critical platform decisions.Key takeaways:- Why CRM decisions today are no longer just about features, but about entire enterprise ecosystems- The real trade-offs between Veeva Vault CRM and Salesforce Life Sciences Cloud in pharma environments- How platform depth across clinical, regulatory, and commercial systems is reshaping migration complexity- The hidden cost layers from integrations to change management, that often define success or failure- How AI-driven narratives from both platforms are influencing (but not yet proving) real-world outcomes- Why early-stage biotech companies are increasingly locking into ecosystems like Veeva Basics from day oneA grounded, real-world conversation on what’s actually happening inside CRM decision rooms today, the pressure, the complexity, and the trade-offs that don’t always show up in presentations.#improzonepodcast #crm #lifesciences #digitaltransformation #customerexperience #pharmatech #aiinhealthcare #improzo

    24 Min.
  3. Season 2 Episode 4.1 CRM Reimagined: Looking at the History with Jason Harlander from Improzo

    30. Apr.

    Season 2 Episode 4.1 CRM Reimagined: Looking at the History with Jason Harlander from Improzo

    Season 2 Episode 4.1 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore the origins of CRM in life sciences and how early decisions continue to shape the industry today. Key takeaways: * How Salesforce started as a SaaS disruptor and built the foundation for modern CRM * Why Veeva’s vertical-first approach transformed pharma CRM adoption * The role of force.com in accelerating innovation without building from scratch * How early strategic decisions helped Veeva capture massive market share * What the Veeva Salesforce split means for the industry today A grounded conversation on where CRM really came from and why understanding its history is key to making better decisions moving forward.

    19 Min.
  4. Season 2 Episode 3: Perception vs. Perspective: Rethinking AI Adoption in Biopharma

    26. März

    Season 2 Episode 3: Perception vs. Perspective: Rethinking AI Adoption in Biopharma

    New Improzone Podcast Episode Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond the hype to examine how AI is actually being adopted across life sciences organizations today. Key takeaways: • The gap between how AI is perceived and how it performs in real-world settings • Why adoption challenges are often operational, not technical • The importance of context, governance, and decision ownership in AI systems • Moving beyond pilots toward execution-focused AI strategies • Why human judgment continues to play a critical role alongside AI A grounded, practical conversation on what it really takes to make AI work in biopharma not just in theory, but in execution. #ImprozonePodcast #AIForLifeSciences #Biopharma #AIAdoption #AgenticAI #ImprozoThoughtLeadership

    26 Min.
  5. Season 2 Episode 2: How MDM and AI are Evolving Together

    18. Feb.

    Season 2 Episode 2: How MDM and AI are Evolving Together

    New Improzone Podcast Episode Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale.Key takeaways:• MDM is shifting from rigid systems of truth to context-driven data philosophies• AI-enabled documentation, observability, and metadata enrichment are changing how data is mastered• Small language models and modular agents outperform one-size-fits-all AI• The real power is human + AI, not automation alone• Entry-level work is changing — but critical thinking and communication matter more than ever A practical, honest conversation about what’s actually working — and what’s next.#ImprozonePodcast #AIForLifeSciences #DataStrategy #MDM #AgenticAI #ImprozoThoughtLeadership

    26 Min.
  6. Season 2 Episode 1: Scaling AI Across the Enterprise

    29. Jan.

    Season 2 Episode 1: Scaling AI Across the Enterprise

    Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams. In the Season 2 premiere of The Improzone, host Jane Urban sits down with Andrew Schwartz (Head of Global IT, KalVista Pharmaceuticals) to break down the roadmap for scaling AI across the enterprise. In this episode, we cover: Shadow IT vs. Enterprise Strategy: Why moving off personal ChatGPT accounts is the first step to security. The "Human-in-the-Loop": How to deploy Agentic AI that assists rather than replaces. Cross-Functional Governance: How to get Legal and QA to say "Yes" to innovation. If you are leading digital transformation in life sciences, this is your blueprint for 2026. #GenerativeAI #LifeSciences #PharmaAI #BiotechInnovation #EnterpriseAI #DigitalTransformation #KalVista #TheImprozone #AIgovernance #Improzo

    53 Min.

  7. 17.12.2025

    Episode 4.4 - The AI Adoption Arc: Externally Facing AI Tools

    We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. From personalized HCP engagement to responsive patient support, we unpack how to deploy AI that builds trust rather than just cutting costs.Don’t leave the most visible part of your business in the analog age.#Improzo #LifeSciences #AIAdoption #PharmaTech #CustomerExperience #GenerativeAI #DigitalTransformation

    23 Min.

  8. 03.12.2025

    Season 1 Episode 4.3 - Using Third-Party Tools with AI Inside

    In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision. In this episode, we unpack: - The Limits of Questionnaires: Why paper surveys fail to catch GenAI hallucinations. - Brand vs. Security: Why a secure bot can still be toxic. - Continuous Validation: Why a one-time pen test is already obsolete. Join Jane Urban and Nathan Trueblood for a masterclass in AI procurement safety. #ArtificialIntelligence #PharmaTech #DigitalHealth #RiskManagement #AIEthics #VendorManagement #TechLeadership #EnkryptAI #Improzo

    21 Min.
Alle anzeigen (13)

Info

You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.

Informationen

  • Erstellt von
    Improzo
  • Jahre aktiv
    2025 - 2026
  • Folgen
    13
  • Bewertung
    Unbedenklich
  • Copyright
    © Improzo
  • Sendungswebsite
    Improzone